Codipral
ActiveSummary
Codipral has been active since 1950 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €275,010 and a net result of €96,097. Equity is growing by ~24.6% per year across the filed fiscal years. The computed 12-month bankruptcy probability is 1.1% (low).
History
Acts, filings and financial milestones
2025
30-10
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 91 days late
2024
31-12
Financial
Highest result since 2018net €96,097 ▲77.7%
Operating result €117,733, net result €96,097, both a record.
08-10
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 69 days late
2023
31-12
Financial
Equity above €200,000Eq €201,966 ▲36.6%
2 profitable years in a row build equity to €201,966.
28-11
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 120 days late
2022
31-12
Financial
Back to profitnet €80,717
Net result €80,717 after one loss-making year.
31-12
Financial
Equity above €100,000Eq €147,887 ▲64.1%
Equity rises from €90,117 to €147,887.
29-11
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 121 days late
2021
31-12
Financial
Weakest financial yearnet -€9,705
Net result drops to -€9,705, the lowest in the series; recovery starts the following year.
05-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 5 days late
2020
30-11
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 122 days late
2019
08-10
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 69 days late
Show earlier events
2018
30-08
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 30 days late
25-05
NBB filing
Annual accounts filed
fiscal year 2016 · full schema · 298 days late
2016
11-08
NBB filing
Annual accounts filed
fiscal year 2015 · full schema · 11 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 7 acts read
About the unread acts
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.